Company / Profit Margin
PALVELLA THERAPEUTICS, INC. Profit Margin History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
43.7%
FY2023
5-year range
-128.5% / 43.7%
FY2019-FY2023
Trend
+134.0%
vs FY2022
Sector context
#9 of 145
Health Care
What the data says
Among 145 Health Care companies, PALVELLA THERAPEUTICS, INC. is in the top 6% for profit margin. Profit Margin returned to growth in FY2023 after 2 years of decline, reaching 43.7%.
Based on SEC 10-K filings.
43.7% in FY2023 with a 5-year CAGR of +113.5%. Top quartile in the Health Care sector.
Improved from -127.0% to 43.7% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +98.7pp
- 5-Year Change
- +113.5pp
- 10-Year Change
- -
Sector benchmark
Top 6% in Health CareTop 6% of 145This company 43.7% Sector average -792.7%
▼
+105.5% above sector average
Key checks
Key Insights
- In FY2023, profit margin increased 134.0% year-over-year.
- Currently 836.3pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | 43.7% | +134.0% |
| FY2022 | -128.5% | -1.2% |
| FY2021 | -127.0% | -130.7% |
| FY2020 | -55.0% | +0.0% |
| FY2019 | -55.0% | +21.2% |
| FY2018 | -69.8% | +82.1% |
| FY2017 | -391.0% | +0.0% |
| FY2016 | -391.0% | +18.5% |
| FY2015 | -479.5% | -161.2% |
As of FY2023 · SEC 10-K Annual Filings · Updated Jun 30, 2026